Species: cattle

Sub-category: calves and adult cows

Age: From 3 months

For the active immunisation of cattle from 3 months of age against Bovine Herpes Virus type 1 (BoHV-1) to reduce the clinical signs of infectious bovine rhinotracheitis (IBR) and field virus excretion.

21 days after completion of the basic vaccination scheme.

Duration of immunity: 6 months after completion of the basic vaccination scheme

Do not use in case of hypersensitivity to the active substance or to any of the excipients.

None

Vaccinate healthy animals only.

None.

A slight increase in body temperature up to 1° C is common within 4 days following vaccination. Occasionally, an increase in rectal temperature up to 1.63º C in adult cows and up to 2.18º C in calves may be observed. This transient rise in temperature is spontaneously resolved within 48 hours without treatment and it is not related to a febrile process.

A transient inflammation at the inoculation site is common in cattle within 72 hours post-vaccination. This slight swelling lasts for less than 24 hours in most cases.

Vaccination might exceptionally cause hypersensitivity reactions. In such cases, an appropriate symptomatic treatment should be administered

Can be used during pregnancy and lactation.

No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product. A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.

Cattle: from the age of 3 months onwards.

Reconstitute the lyophilised tablet with the entire contents of the enclosed solvent to obtain a suspension for injection.

The recommended initial dose is 1 injection of 2 ml of the reconstituted vaccine per animal. The animal should be revaccinated 3 weeks later with the same dose.

Thereafter a single booster dose of 2 ml should be administered every six months.

The method of administration is by intramuscular route, in the neck muscles. The injections should be preferably administered on the alternate sides of the neck. The solvent should be allowed to warm to a temperature between 15 ºC to 20ºC before reconstitution of the lyophilised tablet. Shake well before use. Avoid the introduction of contamination during reconstitution and use. Use only sterile needles and syringes for administration.

No adverse reactions except those mentioned in section 4.6 were observed after the administration of a 10-fold vaccine dose.

Zero Days